The spatial multi-omics revolution in cancer therapy: Precision redefined

Yanhua Du1, Xinyu Ding1, Youqiong Ye1

  • 1Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and Related Genes, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Cell Reports. Medicine
|September 18, 2024
PubMed

Insights

Spatially resolved multi-omics decodes tumor microenvironment complexity. This approach aids in identifying cancer therapy targets and predicting treatment success, despite current integration challenges.

Area of Science:

  • Oncology
  • Genomics
  • Proteomics
  • Spatial Biology

Background:

  • The tumor microenvironment (TME) is a complex ecosystem crucial for cancer progression and treatment response.
  • Understanding the cellular and molecular heterogeneity within the TME is essential for developing effective cancer therapies.
  • Current methods often lack the spatial resolution to fully capture TME complexity.

Purpose of the Study:

  • To discuss the revolutionary impact of spatially resolved multi-omics on cancer therapy.
  • To highlight the role of spatial multi-omics in identifying precise therapeutic targets.
  • To explore the potential of spatial multi-omics in predicting patient treatment responses.

Main Methods:

  • Spatially resolved multi-omics techniques analyze molecular data (genomics, transcriptomics, proteomics) within their native tissue context.
  • Integration of spatial coordinates with multi-omics data allows for detailed mapping of cellular and molecular landscapes.
  • Computational and bioinformatic approaches are employed to interpret complex spatial multi-omics datasets.

Main Results:

  • Spatially resolved multi-omics provides unprecedented insights into tumor heterogeneity and TME composition.
  • This technology enables the identification of novel biomarkers and therapeutic targets based on spatial relationships.
  • Spatial multi-omics data can significantly improve the prediction accuracy of treatment responses.

Conclusions:

  • Spatially resolved multi-omics is a transformative technology for precision oncology.
  • It offers powerful tools for dissecting the TME and guiding therapeutic strategies.
  • Overcoming current technical and analytical challenges is key to fully integrating spatial multi-omics into clinical practice.